Never miss a great news story!
Get instant notifications from Economic Times
AllowNot now


You can switch off notifications anytime using browser settings.

Portfolio

Loading...
Select Portfolio and Asset Combination for Display on Market Band
Select Portfolio
Select Asset Class
Show More
Download ET MARKETS APP

Get ET Markets in your own language

DOWNLOAD THE APP NOW

+91

CHOOSE LANGUAGE

ENG

  • ENG - English
  • HIN - हिन्दी
  • GUJ - ગુજરાતી
  • MAR - मराठी
  • BEN - বাংলা
  • KAN - ಕನ್ನಡ
  • ORI - ଓଡିଆ
  • TEL - తెలుగు
  • TAM - தமிழ்
Drag according to your convenience
ET NOW RADIO
ET NOW
TIMES NOW

Buy Ambuja Cements, target Rs 267.40: ICICI Direct

ETMarkets.com|
Sep 28, 2017, 09.37 AM IST
0Comments
ICICI Direct has a buy call on Ambuja Cements with a target price of Rs 267.40.

The current market price of Ambuja Cements is Rs 261.80.

Time period given by the analyst is intraday when Ambuja Cements price can reach defined target.

ICICI Direct recommended to keep a stop loss at Rs 259.90.

Ambuja Cements, incorporated in the year 1981, is a Large Cap company (having a market cap of Rs 51,954.41 Crore) operating in Cement sector.

Ambuja Cements key Products/Revenue Segments include Cement which contributed Rs 10,430.73 Crore to Sales Value (98.98 per cent of Total Sales), Other Operating Revenue which contributed Rs 84.46 Crore to Sales Value (0.80 per cent of Total Sales), Scrap which contributed Rs 22.74 Crore to Sales Value (0.21 per cent of Total Sales) and Power which contributed Rs 0.22 Crore to Sales Value for the year ending 31-Dec-2016.

For the quarter ended 30-06-2017, the company has reported a Consolidated sales of Rs 6,145.33 Crore, up 9.12 per cent from last quarter Sales of Rs 5,631.90 Crore and up 13.54 per cent from last year same quarter Sales of Rs 5,412.68 Crore.

Company has reported net profit after tax of Rs 715.33 Crore in latest quarter.

The company's top management includes Dr.Omkar Goswami, Mr.Ajay Kapur, Mr.B L Taparia, Mr.Christof Hassig, Mr.Eric Olsen, Mr.Haigreve Khaitan, Mr.Martin Kreigner, Mr.N S Sekhsaria, Mr.Nasser Munjee, Mr.Rajendra P Chitale, Mr.Shailesh Haribhakti, Ms.Usha Sangwan.

Company has SRBC & Co LLP as its auditors.

As on 31-03-2017, the company has a total of 1,985,645,229 shares outstanding.

Also Read

Sell Cadila Healthcare, target Rs 455.30: ICICI Direct

Sell Aurobindo Pharma, target Rs 691.60: ICICI Direct

Sell Dish TV India, target Rs 73.40: ICICI Direct

Buy Marico, target Rs 326.30: ICICI Direct

Comments
Add Your Comments
Disclaimer: This recommendation is analyst's own and does not represent those of economictimes.com & ETMarkets.com. Please consult your financial advisor before taking any position in the stock/s mentioned.

Loading
Please wait...